Skip to content
Pharma GXPGlobal Consulting
All services

Gap Analysis & Audit Readiness

A dry run of your next regulatory inspection — mock audit, documentation review, and shop-floor walkthrough — so findings surface before the real one.

I’ve sat on both sides of the inspection table — supporting USFDA, WHO-Geneva, CDSCO, and ISO 13485 audits from inside the quality unit, and now helping sites prepare for them as an outside reviewer. That combination is what makes a mock audit useful: knowing what an inspector actually asks for, and how a real quality team is stretched trying to answer it live.

A gap analysis engagement is built to surface your findings on your schedule, not the regulator’s — classified by real risk, not documentation neatness, so your team spends its remaining time before inspection closing what actually matters.

How it works

  1. 1

    Scope & standard selection

    Agree the target regulatory standard and inspection scope — facility, product line, or full site.

  2. 2

    Mock inspection

    A structured walkthrough that mirrors how the real authority will inspect: documents, facility, and people.

  3. 3

    Gap classification

    Every observation classified by severity and mapped to the specific clause or expectation it fails.

  4. 4

    CAPA planning

    A realistic, owned CAPA plan — not just a findings list — with dates that hold up under follow-up.

  5. 5

    Verification

    A follow-up pass to confirm CAPAs actually closed before the real inspection date.

Let’s talk

Ready to talk about gap analysis & audit readiness?

Share a little about your site and timeline — I'll follow up within one to two business days with next steps.